Autori: Santoni Matteo
Naslov | Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study (Article) |
Autori | Santoni Matteo ... Popovic Lazar S ![]() |
Info | CANCER IMMUNOLOGY IMMUNOTHERAPY, (2023), vol. 72 br. 9, str. 2961-2970 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|